Abnormality of c-kit oncoprotein in certain patients with chronic myelogenous leukemia – potential clinical significance
- 1 February 2002
- journal article
- Published by Springer Nature in Leukemia
- Vol. 16 (2) , 170-177
- https://doi.org/10.1038/sj.leu.2402341
Abstract
Leukemia is one of the leading journals in hematology and oncology. It is published monthly and covers all aspects of the research and treatment of leukemia and allied diseases. Studies of normal hemopoiesis are covered because of their comparative relevance.Keywords
This publication has 25 references indexed in Scilit:
- The Biology of Chronic Myeloid LeukemiaNew England Journal of Medicine, 1999
- CD7 expression on CD34+ cells from chronic myeloid leukaemia in chronic phaseAmerican Journal of Hematology, 1999
- Relation between microsatellite instability and N-ras mutation and duration of disease free survival in patients with acute leukemiaCancer, 1998
- DCC protein expression in hematopoietic cell populations and its relation to leukemogenesis.Journal of Clinical Investigation, 1996
- Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.Journal of Clinical Investigation, 1993
- Expression and function of c-kit in hemopoietic progenitor cells.The Journal of Experimental Medicine, 1991
- pEF-BOS, a powerful mammalian expression vectorNucleic Acids Research, 1990
- IL3-dependent mouse clones that express B-220 surface antigen, contain ig genes in germ-line configuration, and generate B lymphocytes in vivoCell, 1985
- Fused transcript of abl and bcr genes in chronic myelogenous leukaemiaNature, 1985
- Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22Cell, 1984